These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19481642)

  • 1. The economic impact of assisted reproductive technology: a review of selected developed countries.
    Chambers GM; Sullivan EA; Ishihara O; Chapman MG; Adamson GD
    Fertil Steril; 2009 Jun; 91(6):2281-94. PubMed ID: 19481642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-effectiveness comparison of embryo donation with oocyte donation.
    Finger R; Sommerfelt C; Freeman M; Wilson CK; Wade A; Daly D
    Fertil Steril; 2010 Feb; 93(2):379-81. PubMed ID: 19406398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic disparities in access to ART treatment and the differential impact of a policy that increased consumer costs.
    Chambers GM; Hoang VP; Illingworth PJ
    Hum Reprod; 2013 Nov; 28(11):3111-7. PubMed ID: 23906901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assisted reproductive technology surveillance--United States, 2000.
    Wright VC; Schieve LA; Reynolds MA; Jeng G
    MMWR Surveill Summ; 2003 Aug; 52(9):1-16. PubMed ID: 14532867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assisted reproductive technology surveillance--United States, 2001.
    Wright VC; Schieve LA; Reynolds MA; Jeng G; Kissin D
    MMWR Surveill Summ; 2004 Apr; 53(1):1-20. PubMed ID: 15123982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility preservation for social indications: a cost-based decision analysis.
    Hirshfeld-Cytron J; Grobman WA; Milad MP
    Fertil Steril; 2012 Mar; 97(3):665-70. PubMed ID: 22265038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic implications of insurance coverage for in vitro fertilization in the United States. A review.
    Omurtag KR; Styer AK; Session D; Toth TL
    J Reprod Med; 2009; 54(11-12):661-8. PubMed ID: 20120898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptable cost for the patient and society.
    Chambers GM; Adamson GD; Eijkemans MJ
    Fertil Steril; 2013 Aug; 100(2):319-27. PubMed ID: 23905708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economics of assisted reproductive technologies.
    Ata B; Seli E
    Curr Opin Obstet Gynecol; 2010 Jun; 22(3):183-8. PubMed ID: 20125015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro fertilization (IVF) versus gonadotropins followed by IVF as treatment for primary infertility: a cost-based decision analysis.
    Kansal-Kalra S; Milad MP; Grobman WA
    Fertil Steril; 2005 Sep; 84(3):600-4. PubMed ID: 16169391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insurance mandates and trends in infertility treatments.
    Henne MB; Bundorf MK
    Fertil Steril; 2008 Jan; 89(1):66-73. PubMed ID: 17482603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diversity of regulation and public financing of IVF in Europe and its impact on utilization.
    Berg Brigham K; Cadier B; Chevreul K
    Hum Reprod; 2013 Mar; 28(3):666-75. PubMed ID: 23223400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of transferring one through five embryos per in vitro fertilization cycle from various payor perspectives.
    Little SE; Ratcliffe J; Caughey AB
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):593-601. PubMed ID: 16946220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of in vitro fertilization.
    Collins J
    Semin Reprod Med; 2001 Sep; 19(3):279-89. PubMed ID: 11679909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation to limit the number of embryos transferred.
    Dickey RP
    Fertil Steril; 2007 Dec; 88(6):1554-61. PubMed ID: 17481621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts.
    Griffiths A; Dyer SM; Lord SJ; Pardy C; Fraser IS; Eckermann S
    Hum Reprod; 2010 Apr; 25(4):924-31. PubMed ID: 20106837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assisted reproductive technologies (ART) in Canada: 2002 results from the Canadian ART Register.
    Gunby J; Daya S;
    Fertil Steril; 2006 Nov; 86(5):1356-64. PubMed ID: 17070192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha.
    Wechowski J; Connolly M; Schneider D; McEwan P; Kennedy R
    Fertil Steril; 2009 Apr; 91(4):1067-76. PubMed ID: 18339384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assisted reproductive technologies in Canada: 2005 results from the Canadian Assisted Reproductive Technologies Register.
    Gunby J; Bissonnette F; Librach C; Cowan L;
    Fertil Steril; 2009 May; 91(5):1721-30. PubMed ID: 18423460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fiscal outcome of artificial conception in Brazil--creating citizens in developing countries.
    Kröger GB; Ejzenberg D
    Hum Reprod; 2012 Jan; 27(1):142-5. PubMed ID: 22068637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.